Prescription-Eyeglasses.com - Brand name eyeglasses, Frames, contact lenses, Sunglasses, Safety Glasses, and Quality Replacement Lenses at the most affordable prices

Shop Our Products

News

Real-world study shows long-term safety, efficacy of Iluvien in DME

Real-world long-term study outcomes showed sustained safety and efficacy of Iluvien in patients with diabetic macular edema. The data also showed that IOP and VA outcomes were very similar to those reported in the pivotal FAME trials. It should be noted that real-world studies, particularly in the treatment of DME, very rarely confirmed the good outcomes of randomized clinical trials, Ramin Khoramnia, MD, said at the virtual Association for Research in Vision and Ophthalmology meeting. The Iluvi...

>Read More

Educational cartoon improves patch compliance in kids with amblyopia

Use of a short educational cartoon on patching for occlusion therapy improved compliance among children with amblyopia. Compliance with occlusion therapy among children is often problematic, Saeed Aljohani, OD, a PhD candidate at Salus University, said during his ARVO presentation. We created a 4-minute educational color cartoon video that explains the importance of wearing the eye patch to children. Aljohani said that the story of the cartoon was written under supervision of a speech specialist...

>Read More

Eyenovia resumes phase 3 trial enrollment for progressive myopia treatment

Eyenovia resumed patient enrollment for its phase 3 study of a progressive myopia treatment following a pause due to the COVID-19 pandemic, according to a press release. The U.S.-based, multicenter, randomized, double-masked CHAPERONE study is aiming to enroll more than 400 children between the ages of 3 and 12 years. Subjects will receive either one of two concentrations of MicroPine or placebo. The study is evaluating the safety and efficacy of MicroPine in the reduction of progressive myopia ...

>Read More

OWL addresses racism in ophthalmology

Racism is a public health problem, and diversity alone is not a cure, Renee Bovelle, MD, said in a webinar hosted by Ophthalmic World Leaders. In a panel discussion convened to confront issues of racism in ophthalmology, Bovelle and two other Black ophthalmologists, Frank Bowden, MD, and Connie Okeke, MD, agreed that access is key, not only for opening educational opportunities but also for advancing career goals. When you have someone who looks like you, someone you can emulate, it definitely c...

>Read More

Binocular vision problems after cataract surgery linked to prior anomalies

Cataract surgery did not significantly correlate with risk for binocular vision problems; rather, the main risk factor was preexisting non-strabismic binocular vision anomalies, according to a study. Qing-Qing Tan, MD, PhD, from the North Sichuan Medical College, China, and colleagues found during a literature search that significant indications of strabismic and non-strabismic binocular vision problems after cataract surgery. However, they also found a number of significant limitations. While r...

>Read More

Novartis AG, Novartis Greece, Alcon Pte Ltd resolve criminal cases for $345 million

Novartis AG, Novartis Hellas S.A.C.I. and Alcon Pte Ltd have agreed to a payment of more than $345 million to resolve violations of the Foreign Corrupt Practices Act. According to a U.S. Department of Justice press release, Novartis Hellas S.A.C.I. (Novartis Greece), a subsidiary of Novartis AG, engaged in a scheme to bribe employees of state-owned and state-controlled hospitals and clinics in Greece to increase the sale of Novartis-branded pharmaceutical products. The company specifically paid ...

>Read More

Blood type may contribute to likelihood of acquiring COVID-19

A patients blood type plays a role in the likelihood of developing COVID-19, data from two genetic studies show. An infectious disease expert unaffiliated with the studies told Healio Primary Care that the results are possible, but with some important caveats. In the first study, which appeared in The New England Journal of Medicine, David Ellinghaus, a scientist at the Institute of Clinical Molecular Biology in Germany, and colleagues analyzed nearly 8.6 million single nucleotide polymorphisms ...

>Read More